The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma (Q35151800)

6 August 2017

The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma (English)

1 reference

6 August 2017

alcoholic liver disease

1 reference

Keun Hee Kang

1

1 reference

6 August 2017

Ji Hoon Kim

2

1 reference

6 August 2017

Seong Hee Kang

3

1 reference

6 August 2017

Beom Jae Lee

4

1 reference

6 August 2017

Yeon Seok Seo

5

1 reference

6 August 2017

Hyung Joon Yim

6

1 reference

6 August 2017

Jong Eun Yeon

7

1 reference

6 August 2017

Jong Jae Park

8

1 reference

6 August 2017

Jae Seon Kim

9

1 reference

6 August 2017

Young Tae Bak

10

1 reference

6 August 2017

Kwan Soo Byun

11

1 reference

6 August 2017

1 March 2015

1 reference

6 August 2017

1 reference

6 August 2017

9

1 reference

6 August 2017

2

1 reference

6 August 2017

224-230

1 reference

Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Vitamins K and D status in stages 3-5 chronic kidney disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

PIVKA-II-producing advanced gastric cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Recent advances in hepatic vitamin K metabolism and function

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Mechanism of Cephalosporin-induced Hypoprothrombinemia: Relation to Cephalosporin Side Chain, Vitamin K Metabolism, and Vitamin K Status

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Abnormal prothrombin in acute hepatic failure: the characterization and clinical evaluation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Studies on the mechanism of elevation of serum PIVKA-II levels in alcoholic liver cirrhosis

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351030

Plasma prothrombin during treatment with Dicumarol. I. Immunochemical determination of its concentration in plasma

27 September 2018

1 reference

12 December 2020

Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group

1 reference

12 December 2020

Vitamin K deficiency in chronic alcoholic males

1 reference

12 December 2020

In vivo effects of beta-lactam antibiotics and heterocyclic thiol compounds on vitamin K-dependent carboxylation activity and blood coagulation factors in vitamin K-deficient rats

1 reference

12 December 2020

Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients

1 reference

12 December 2020

Plasma abnormal prothrombin (PIVKA-II): a new and reliable marker for the detection of hepatocellular carcinoma

1 reference

12 December 2020

Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer

1 reference

12 December 2020

Determination of Optimum Cutoff Levels of Plasma Des-&gamma;-Carboxy Prothrombin and Serum &alpha;-Fetoprotein for the Diagnosis of Hepatocellular Carcinoma using Receiver Operating Characteristic Curves

1 reference

12 December 2020

Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes

1 reference

12 December 2020

Normotest and abnormal prothrombin in liver transplantation

1 reference

12 December 2020

The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin

1 reference

12 December 2020

The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma

1 reference

12 December 2020

Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma

1 reference

12 December 2020

Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity

1 reference

12 December 2020

A variant of des-gamma-carboxy prothrombin was increased in alcoholic liver disease without hepatocellular carcinoma

1 reference

12 December 2020

[Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve]

1 reference

12 December 2020

Identifiers

DOI

10.5009/GNL14047

1 reference

6 August 2017

1 reference

6 August 2017

1 reference